Patents Assigned to AkaRx, Inc.
  • Publication number: 20110224226
    Abstract: Disclosed in certain embodiments is an oral pharmaceutical dosage form of a pharmaceutically acceptable excipient and an effective amount of 1-(3-chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]carbamoyl} pyridin-2-yl)piperadine-4-carboxylic acid (Formula I) or a pharmaceutically acceptable salt thereof, to increase platelet levels in humans.
    Type: Application
    Filed: March 31, 2011
    Publication date: September 15, 2011
    Applicant: AKARX, Inc.
    Inventors: Robert E. DESJARDINS, Rudolph Lucek
  • Publication number: 20080039475
    Abstract: Disclosed in certain embodiments is an oral pharmaceutical dosage form comprising a pharmaceutically acceptable excipient and an effective amount of 1-(3-chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]carbamoyl}pyridin-2-yl)piperadine-4-carboxylic acid (Formula I) or a pharmaceutically acceptable salt thereof, to increase platelet levels in humans.
    Type: Application
    Filed: August 8, 2007
    Publication date: February 14, 2008
    Applicant: AkaRx, Inc.
    Inventors: Robert Desjardins, Rudolph Lucek